CMS Open Payments · Program Year 2024
SNAP Diagnostics LLC
SNAP Diagnostics LLC reported $687,164.18 across General Payments, Research, and Ownership to 77 physicians and teaching hospitals across 78 transactions.
- $687.2K Above-median payer
- All-tracks total
- 78 Below-median volume
- Transactions
- 77 Below-median reach
- Recipients
- +$38.2K
- General Payments vs PY2023
SNAP Diagnostics LLC reported $687,164.18 across all CMS Open Payments tracks (General + Research + Ownership) to 77 physicians and teaching hospitals in Program Year 2024 - ranking #696 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $514,953.88, averaging $8.9K per recipient.
How SNAP Diagnostics LLC's $687.2K all-tracks total breaks down
SNAP Diagnostics LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
15/100
Total payments
F
16/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer snap-diagnostics-llc SNAP Diagnostics LLC
$687.2K · #696/1,925 · 0.0% industry · PY2024
- TOT $687.2K
- RANK #696
- SHARE 0.0%
- TXN 78
- RCP 77
- CAT 2
- GEN $515.0K
- ΔGEN +$38.2K
- TOP1 38.9%
- PY 2024
Volume peers
Nearest volume peer: Tempus AI, Inc ($683.5K)
SNAP Diagnostics LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
SNAP Diagnostics LLC's CMS-reported General Payments increased by $38.2K (+8.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SNAP DIAGNOSTICS LLCPY2023: SNAP DIAGNOSTICS LLCPY2024: SNAP Diagnostics LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $476,782.01
- PY2024
- $514,953.88
What the Data Shows for SNAP Diagnostics LLC
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For SNAP Diagnostics LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $514.9K, accounting for 100.0% of this company's General Payments and 72 transactions.
General Payment Breakdown by Type
SNAP Diagnostics LLC made 2 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $514.9K, 100.0% of General Payments.
How SNAP Diagnostics LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $514.9K | 72 | 100.0% |
| Food and Beverage | $72.88 | 5 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $475,776.00 (92.4%) of $514,953.88 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for SNAP Diagnostics LLC
The five named recipients with the highest reported General Payments from this company
- 1
Lisa Shives
$200,304.00 across 12 reported transactions
- 2
Roukan Jazayerli
$102,675.00 across 12 reported transactions
- 3
Muhammad Najjar
$80,497.00 across 12 reported transactions
- 4
Dianne Augelli
$50,000.00 across 12 reported transactions
- 5
Simmy Jerry Pinto
$42,300.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
SNAP Diagnostics LLC's spend rank (#696 of 1,925, top 36% by spend) and concentration rank (#672 of 1,838, top 37% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Dash Medical Gloves LLC : $1.2K total payments, HHI 2417
- Vital Orthopedics Llc : $1.7K total payments, HHI 2411
- Bodycad USA Corp : $48.6K total payments, HHI 2405
- Medela AG : $14.7K total payments, HHI 2395
- Kyowa Kirin Co., Ltd : $41.2K total payments, HHI 2391
- Miach Orthopaedics, Inc. : $1.0M total payments, HHI 2381
- SNAP Diagnostics LLC (this company) : $515.0K total payments, HHI 2374
- DeRoyal Industries, Inc. : $17.5K total payments, HHI 2374
- AGEPHA Pharma FZ LLC : $93.7K total payments, HHI 2373
- Access Vascular Inc : $27.0K total payments, HHI 2373
- FloSpine LLC : $48.7K total payments, HHI 2372
- RedDress USA, Inc. : $184.0K total payments, HHI 2360
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as SNAP Diagnostics LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about SNAP Diagnostics LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with SNAP Diagnostics LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Kaneka Medical America LLC
Synapse Surgical LLC
Extremity Medical
Verathon Inc.
Day One Biopharmaceuticals
Put this to use
SNAP Diagnostics LLC ranks #696 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just SNAP Diagnostics LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.